Anthony Mato

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi request reprint Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours
    Anthony R Mato
    John Theurer Cancer Center, Lymphoma Division, Hackensack University Medical Center, Hackensack, NJ, USA
    Cancer Biol Ther 9:585-9. 2010
  2. ncbi request reprint Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and management
    Anthony R Mato
    Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Cancer Biol Ther 6:1867-70. 2007
  3. ncbi request reprint Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies
    Anthony Mato
    Hematology and Oncology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Cancer Biol Ther 8:1095-1100. 2009
  4. doi request reprint A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia
    Donald E Tsai
    Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Cancer Res 14:5619-25. 2008
  5. doi request reprint Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging
    Elise A Chong
    Division of Hematology Oncology, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Clin Nucl Med 33:692-3. 2008
  6. doi request reprint Novel strategies for relapsed and refractory acute myeloid leukemia
    Anthony R Mato
    Abramson Cancer Center and Division of Hematology and Oncology, Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Curr Opin Hematol 15:108-14. 2008
  7. ncbi request reprint A predictive model for the detection of tumor lysis syndrome during AML induction therapy
    Anthony R Mato
    Hematologic Malignancies Program, Division of Hematology and Oncology, Department of Internal Medicine, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA
    Leuk Lymphoma 47:877-83. 2006

Detail Information

Publications7

  1. ncbi request reprint Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours
    Anthony R Mato
    John Theurer Cancer Center, Lymphoma Division, Hackensack University Medical Center, Hackensack, NJ, USA
    Cancer Biol Ther 9:585-9. 2010
    ..This study was designed to determine whether serum lactate, measured at the time of FN, is associated with the development of septic shock in hospitalized hematologic malignancy (HM) patients...
  2. ncbi request reprint Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and management
    Anthony R Mato
    Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Cancer Biol Ther 6:1867-70. 2007
    ..We present the case of an 82 yr old male with newly diagnosed PCL and two years of subsequent follow up. This report highlights the utility of a multimodality imaging approach in the diagnosis and management of PCL...
  3. ncbi request reprint Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies
    Anthony Mato
    Hematology and Oncology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Cancer Biol Ther 8:1095-1100. 2009
    ..The systemic inflammatory response syndrome (SIRS) criteria have not been validated in patients with hematologic malignancies (HM)...
  4. doi request reprint A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia
    Donald E Tsai
    Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Cancer Res 14:5619-25. 2008
    ..We therefore conducted a phase I dose escalation study to assess the maximum tolerated dose, toxicities, and activity of bexarotene in patients with non-M3 acute myeloid leukemia (AML)...
  5. doi request reprint Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging
    Elise A Chong
    Division of Hematology Oncology, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Clin Nucl Med 33:692-3. 2008
  6. doi request reprint Novel strategies for relapsed and refractory acute myeloid leukemia
    Anthony R Mato
    Abramson Cancer Center and Division of Hematology and Oncology, Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Curr Opin Hematol 15:108-14. 2008
    ..We reviewed each report to identify studies that used a phase II or III design and that included a majority of adults with non-M3 acute myeloid leukemia described as 'relapsed' or 'refractory'...
  7. ncbi request reprint A predictive model for the detection of tumor lysis syndrome during AML induction therapy
    Anthony R Mato
    Hematologic Malignancies Program, Division of Hematology and Oncology, Department of Internal Medicine, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA
    Leuk Lymphoma 47:877-83. 2006
    ..This analysis may lay the groundwork for the development of the first evidence-based guidelines for TLS monitoring and management in this patient population...